These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9723081)

  • 1. [A form for soliciting the measurement of drug plasma level and its use in a university hospital].
    Espinoza E; Kramer V; Saavedra H; Biagini L
    Rev Med Chil; 1991 Nov; 119(11):1284-90. PubMed ID: 9723081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.
    Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR
    J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of requests for serum digoxin concentrations: experience from an Australian regional health service.
    Ellington C; Grgurinovich N; Miners JO; Mangoni AA
    Br J Clin Pharmacol; 2007 May; 63(5):623-7. PubMed ID: 17073890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin therapeutic drug monitoring: an audit and review.
    Sidwell A; Barclay M; Begg E; Moore G
    N Z Med J; 2003 Dec; 116(1187):U708. PubMed ID: 14752536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease.
    Sharma R; Guy M; Rudenski A; Lamerton E; Kalra PA
    QJM; 2009 Oct; 102(10):747-50. PubMed ID: 19602599
    [No Abstract]   [Full Text] [Related]  

  • 6. [Digoxin].
    Yamamoto K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():403-5. PubMed ID: 15658349
    [No Abstract]   [Full Text] [Related]  

  • 7. Pitfalls in TDM of antibiotic drugs: analytical and modelling issues.
    Neef C; Touw DJ; Harteveld AR; Eerland JJ; Uges DR
    Ther Drug Monit; 2006 Oct; 28(5):686-9. PubMed ID: 17038886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring Dimension RxL Max clinical chemistry system.
    Mendu DR; Chou PP; Soldin SJ
    Ther Drug Monit; 2007 Oct; 29(5):632-7. PubMed ID: 17898655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring--its highs and lows (peaks and troughs).
    Nardini JM
    Nephrol Nurs J; 2000 Dec; 27(6):561-2. PubMed ID: 16649336
    [No Abstract]   [Full Text] [Related]  

  • 10. Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range.
    Morris RG; Jones TE; Goldsworthy SJ; Wagner TJ; Ho H; Horowitz JD
    Ther Drug Monit; 2006 Jun; 28(3):454-7. PubMed ID: 16778733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic monitoring].
    Roncoroni AJ; Bianchi L
    Medicina (B Aires); 1987; 47(2):163-6. PubMed ID: 3695917
    [No Abstract]   [Full Text] [Related]  

  • 12. The practice of digoxin therapeutic drug monitoring.
    Barclay M; Begg E
    N Z Med J; 2003 Dec; 116(1187):U704. PubMed ID: 14752532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Digoxin].
    Kotaki H; Iga T
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():950-3. PubMed ID: 8753596
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved compliance with a gentamicin prescribing policy after introduction of a monitoring form.
    Rogers MS; Cullen MM; Boxall EM; Chadwick PR
    J Antimicrob Chemother; 2005 Sep; 56(3):566-8. PubMed ID: 16076879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Digoxin plasma levels in four different prescription schedules of common use in clinical practice].
    Reinbach R; Villa L; Giraudo P; Venegas R; Fernández P
    Rev Med Chil; 2003 Apr; 131(4):373-80. PubMed ID: 12870231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Digoxin].
    Yamamoto K
    Nihon Rinsho; 1999 Sep; 57 Suppl():387-9. PubMed ID: 10543134
    [No Abstract]   [Full Text] [Related]  

  • 17. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates.
    Pullen J; Stolk LM; Nieman FH; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Apr; 28(2):226-31. PubMed ID: 16628135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of therapeutic drug monitoring of digoxin and gentamicin in the saliva of children.
    Berkovitch M; Bistritzer T; Aladjem M; Burtin P; Dagan T; Chen-Levi Z; Freedom R; Koren G
    Ther Drug Monit; 1998 Jun; 20(3):253-6. PubMed ID: 9631920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dangerous combination.
    Lilley LL; Guanci R
    Am J Nurs; 1998 May; 98(5):10. PubMed ID: 9612423
    [No Abstract]   [Full Text] [Related]  

  • 20. [Principles of therapeutic drug monitoring].
    Widmer N; Csajka C; Werner D; Grouzmann E; Decosterd LA; Eap CB; Biollaz J; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1644-8. PubMed ID: 18767290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.